Drugmakers delay in-demand medicines in effort to evade Biden's new pricing rules

Retrieved on: 2023-12-24 20:17:41

Tags for this article:

Pharmacy

Drug pricing

Pharmaceuticals policy

Healthcare reform in the United States

Pfizer

Research and development in the United States

Pharmaceutical industry

Alnylam Pharmaceuticals

Medication costs

AbbVie

Seagen

Healthcare in the United States

United States

Click the tags to see associated articles and topics

Drugmakers delay in-demand medicines in effort to evade Biden's new pricing rules. View article details on HISWAI: https://www.postguam.com/business/drugmakers-delay-in-demand-medicines-in-effort-to-evade-bidens-new-pricing-rules/article_d21afbae-a1fe-11ee-89c8-d7f061a70672.html

Excerpt

... New Enterprise Associates and a Pfizer board member. Toya Sarno Jordan ... New Enterprise Associates and a Pfizer board member. Since 2020, Relay ...

Article found on: www.postguam.com

View Original Article